unlearn.ai
verifiedUses AI digital twins to streamline clinical trials; differentiated with real traffic.
What it does
Unlearn uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making. Their platform simulates outcomes for every participant at the beginning of a clinical study, predicting every clinical outcome at every future time point with precision. They generate digital twins of patients in studies, delivered through a state-of-the-art, easy-to-use platform that minimizes trial failure, cuts costs, and accelerates timelines.
How to use: Unlearn's platform allows users to design and run smaller clinical trials, explore predicted outcomes for subgroups of participants, and simulate protocol scenarios in early stages of trial design. Users can book a demo to learn how Unlearn can support their study.
Core features
- ✦Digital twin generation for clinical trial participants
- ✦Outcome prediction with high precision
- ✦Trial design simulation
- ✦Real-time insights and data-driven decision-making
Use cases
- →Accelerating trial timelines by designing smaller, more powerful studies
- →Enhancing decision-making by exploring predicted outcomes for participant subgroups
- →De-risking trial design by simulating protocol scenarios
Reviews
Big-picture takes: what it's for and whether it delivers. High-engagement videos from YouTube — not sponsored.
Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734
This Week in Startups · 74K views